TNGX — Tango Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Tango Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.31	485	366	337	258
Net Total Accounts Receivable
Net Total Receivables	—	2	2	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.5	492	375	347	266
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	6.09	57.8	53.4	47.6
Long Term Investments
Other Long Term Assets
Total Assets	168	500	436	403	316
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.114	40.7	55.5	45.9	38.2
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.95	155	187	149	117
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	162	345	249	253	200
Total Liabilities & Shareholders' Equity	168	500	436	403	316
Total Common Shares Outstanding